The New England Journal of Medicine

Original Articles
Response to Imatinib Mesylate in Patients with Chronic Myeloproliferative Diseases...
J. F. Apperley and Others - 15 Aug, 2002

NEJM PowerPoint Slide Set This PowerPoint Slide Set is a value added service that requires an individual subscription.

Sign In

Already a print subscriber? Activate your online access

Not a Subscriber?

Get full access to NEJM Online now with a FREE TRIAL!

Free Trial

Or, purchase full access to this
PowerPoint Slide Set for $10


Advertisement
Advertisement

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.